Globally, studies published in leading oncology journals show that radiation before surgery can reduce tumor size and improve surgical outcomes in several solid cancers, with response rates exceeding 60–70% in select cases. This approach, clinically referred to as neoadjuvant radiation therapy, is transforming how cancers are prepared for surgery—turning previously complex or high-risk operations into safer, more effective procedures.
At the forefront of this transformation in India is Dr Mathangi J, Senior Consultant & In-charge of Radiation Oncology at Gleneagles Cancer Institute, Bangalore. With over two decades of experience and more than 12,000 successfully treated patients, Dr Mathangi brings global expertise, advanced technology, and deeply personalized care to every patient undergoing neoadjuvant treatment.
Radiation before surgery, also known as neoadjuvant treatment, is a carefully planned course of radiation delivered before surgical removal of a tumor. Its primary goal is to shrink or downstage the cancer, making surgery more precise, less invasive, and more likely to achieve clear margins.
This strategy is especially valuable in cancers where tumor size, location, or proximity to critical organs can complicate surgery. By using targeted radiation in advance, oncologists can reduce tumor burden while preserving surrounding healthy tissue.
Neoadjuvant radiation therapy works by damaging the DNA of cancer cells, preventing them from dividing and causing them to gradually die off. Unlike surgery, which removes visible disease, radiation targets both the main tumor and microscopic cancer cells that may extend beyond what imaging reveals.
Under Dr Mathangi’s leadership, treatment planning is performed using advanced imaging, including CT simulation and image-guided techniques. This allows for millimeter-level precision, ensuring that radiation is delivered exactly where it is needed—no more, no less.
Tumor shrink radiation is one of the most powerful advantages of pre-operative radiotherapy. When tumors reduce in size or retract from nearby organs, surgeons gain better visibility and control during the operation.
This is particularly impactful in cancers such as:
By shrinking tumors beforehand, Dr Mathangi helps patients avoid more radical surgeries and, in some cases, preserve vital functions such as speech, swallowing, or organ integrity.
Pre-surgery radiotherapy is not a one-size-fits-all solution. It is recommended after careful multidisciplinary evaluation involving radiation oncologists, surgical oncologists, and medical oncologists.
Patients who may benefit include those with:
Dr Mathangi’s depth of experience allows her to identify which patients will gain the maximum advantage from this approach, avoiding unnecessary treatment while optimizing outcomes for those who need it.
Cancer prep radiation is considered safe and well-established when delivered using modern techniques. Advances such as IGRT, RapidArc, gated radiotherapy, and stereotactic methods have significantly reduced side effects compared to older radiation approaches.
Under Dr Mathangi’s care, every treatment plan is designed to:
Her international training in Germany and Denmark ensures that patients in India receive care aligned with the highest global standards.
Dr Mathangi is not only a clinician but a pioneer in advanced radiotherapy. She played a key role in installing the Asia Pacific’s first TrueBeam STx machine, a milestone that reflects her commitment to technological excellence.
Her expertise spans advanced modalities such as:
This level of precision is especially critical in neoadjuvant treatment, where the goal is maximum tumor response with minimal disruption to surgical timelines.
Radiation before surgery is rarely used in isolation. It is part of a carefully sequenced plan that may include chemotherapy, targeted therapy, immunotherapy, and surgery.
Dr Mathangi collaborates closely with multidisciplinary teams to ensure seamless transitions between treatments. This coordination reduces delays, improves tolerance, and enhances overall outcomes.
Patients often report greater confidence knowing that their care is being guided by a specialist who oversees not just radiation delivery, but the entire pre-surgical strategy.
One of the biggest challenges in cancer care is timing. Delaying neoadjuvant radiation therapy when it is clinically indicated can result in:
Patients who choose early evaluation with Dr Mathangi gain clarity, direction, and access to advanced options that may not be available later in the disease course.
Dr Mathangi J is a Senior Radiation Oncologist and In-charge of the Radiation Oncology Department at Gleneagles Cancer Institute, Bangalore. She holds an MBBS, DMRT, and DNB, and has completed advanced international training in stereotactic techniques, IGRT, RapidArc, and intraoperative radiotherapy.
With over 20 years of experience and leadership as Director of the Fellowship in Advanced Radiotherapy Techniques affiliated with RGUHS, Dr Mathangi is widely respected for her clinical judgment, technical excellence, and patient-centered care.
Choosing neoadjuvant treatment is a decision that can shape surgical success and long-term outcomes. When guided by the expertise of Dr Mathangi, patients receive not just radiation, but a thoughtfully designed pathway toward better cancer control.
To book an appointment, submit your contact information through the form at https://drmathangi.com/contact/. Dr Mathangi’s team will schedule your consultation and guide you through the next steps with care and clarity.
Radiation before surgery is a planned approach where radiation therapy is delivered prior to an operation to treat cancer. The goal is to weaken cancer cells, reduce the size of the tumor, and make surgical removal more precise. Dr. Mathangi evaluates each patient’s diagnosis, imaging, and overall health to determine whether this timing can improve surgical outcomes and long-term control.
neoadjuvant radiation therapy is designed to treat the tumor before surgery so that surgeons can operate on a smaller, better-defined target. This may allow for less extensive surgery, clearer margins, and better preservation of surrounding healthy tissue. Dr. Mathangi carefully plans radiation doses using advanced imaging to balance effectiveness with safety.
tumor shrink radiation is not used for every cancer type or stage. It is most commonly recommended when reducing tumor size can significantly improve the success of surgery. Dr. Mathangi conducts a multidisciplinary review with surgeons and medical oncologists to ensure this approach is appropriate for the specific cancer biology and patient condition.
pre-surgery radiotherapy planning involves detailed scans, precise contouring of the tumor area, and customized dose calculations. Dr. Mathangi focuses on targeting cancer cells while protecting nearby organs, ensuring that patients are well-prepared for surgery with minimal added risk.
cancer prep radiation is one part of a coordinated treatment plan that may also include chemotherapy, surgery, and post-operative care. Dr. Mathangi guides patients through each step, explaining timelines, expected effects, and how this preparation supports smoother surgery and recovery.
Side effects vary depending on the treatment area and dose, but they are closely monitored. As part of neoadjuvant treatment, Dr. Mathangi emphasizes symptom management, nutrition guidance, and regular follow-ups so patients remain fit for surgery when the time comes.
Dr. Mathangi combines clinical expertise with a patient-centered approach, focusing on precision, safety, and clear communication. Her solutions are tailored to each individual, ensuring that radiation before surgery is integrated seamlessly with surgical planning for the best possible outcomes.
Your information is kept strictly confidential.
